Stock Earnings

Question 1

Teva Pharmaceutical Industries Ltd'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Teva Pharmaceutical Industries Ltd'in toplam varlıkları $39,326 olup, net loss $-1,639'dir.

Question 2

TEVJF'ün temel finansal oranları nelerdir?

Accepted Answer

Teva Pharmaceutical Industries Ltd'in cari oranı 1.15, net kâr marjı -9.9, hisse başına satış $14.62'dir.

Question 3

Teva Pharmaceutical Industries Ltd'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Teva Pharmaceutical Industries Ltd largest revenue segment is Generics, Innovative Medicines and Biopharmaceuticals, at a revenue of 61,240,545,677 in the most earnings release.For geography, United States is the primary market for Teva Pharmaceutical Industries Ltd, at a revenue of 29,739,273,692.

Question 4

Teva Pharmaceutical Industries Ltd kârlı mı?

Accepted Answer

no, son mali tablolara göre Teva Pharmaceutical Industries Ltd'in net loss $-1,639'dir.

Question 5

Teva Pharmaceutical Industries Ltd'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Teva Pharmaceutical Industries Ltd'in yükümlülüğü 33,953'dir.

Question 6

Teva Pharmaceutical Industries Ltd'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Teva Pharmaceutical Industries Ltd'in toplam tedavüldeki hisse sayısı 1,133.83'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	16,628	16,544	15,846	14,925	15,878	16,659
Revenue Growth (YoY)	2%	4%	6%	-6%	-5%	-1%
Cost of Revenue	8,167	8,252	7,870	7,487	8,014	8,870
Gross Profit	8,461	8,292	7,976	7,438	7,864	7,789
Selling, General & Admin	3,754	3,702	3,498	3,445	3,402	3,519
Research & Development	978	998	953	838	967	997
Operating Expenses	4,704	4,704	4,436	4,253	4,446	4,622
Other Non Operating Income (Expenses)	-17	-48	-66	-62	-70	-1
Pretax Income	-74	-1,284	-624	-3,163	658	-4,406
Income Tax Expense	93	676	-7	-643	211	-168
Net Income	-158	-1,639	-559	-2,446	417	-3,990
Net Income Growth	-67%	193%	-77%	-687%	-110%	299%
Shares Outstanding (Diluted)	1,161	1,131	1,119	1,110	1,107	1,095
Shares Change (YoY)	2%	1%	1%	0%	1%	0%
EPS (Diluted)	-0.14	-1.44	-0.49	-2.2	0.37	-3.64
EPS Growth	-65%	190%	-77%	-685%	-110%	298%
Free Cash Flow	890	749	842	1,042	236	638
Free Cash Flow Per Share	0.76	0.66	0.75	0.93	0.21	0.58
Gross Margin	50.88%	50.12%	50.33%	49.83%	49.52%	46.75%
Operating Margin	22.59%	21.68%	22.34%	21.34%	21.52%	19.01%
Profit Margin	-0.95%	-9.9%	-3.52%	-16.38%	2.62%	-23.95%
Free Cash Flow Margin	5.35%	4.52%	5.31%	6.98%	1.48%	3.82%
EBITDA	4,779	4,647	4,693	4,493	4,748	4,724
EBITDA Margin	28.74%	28.08%	29.61%	30.1%	29.9%	28.35%
D&A For EBITDA	1,022	1,059	1,153	1,308	1,330	1,557
EBIT	3,757	3,588	3,540	3,185	3,418	3,167
EBIT Margin	22.59%	21.68%	22.34%	21.34%	21.52%	19.01%
Effective Tax Rate	-125.67%	-52.64%	1.12%	20.32%	32.06%	3.81%

Teva Pharmaceutical Industries Ltd (TEVJF) Price

TEVJF Stock Price Chart

TEVJF Income

Follow-Up Questions